返回 Agenda
Session 7: Convergence & Reliance
Session Chair(s)
Susanne Ausborn, PhD
Global Head International Regulatory Policy
Roche, Switzerland
Frank Montgomery, PhD
Global Head Regulatory CMC, GRAPSQA
AstraZeneca, United Kingdom
This Workshop will bring together regulators from different national/regional/global bodies and industry to discuss ongoing and future efforts to drive regional and global regulatory convergence. WHO has rolled out their Good Regulatory Practice and Good Reliance Practice guidelines and there are numerous examples around the world where regulatory reliance pathways, work-sharing and recognition have been established and/or are further developed. But more needs to be done to enable efficient and effective responses to public health emergencies and beyond.
Panellists from Regulatory Agencies and Industry representatives will share their experiences with different "working models" and reflect on the value of collaboration, what to take further from the learnings from the Pandemic and how to address existing barriers to ensure timely and continuous supply of medicines to patients in need around the globe.
Learning Objective : At the conclusion of this session, participants should be able to:
- Contribute to the establishment of a best practices framework for managing regulatory information and processes
- Understand the benefit and structure of the RIM Reference Model and apply the structure, content, and nomenclature to RIM planning, design and implementation activities
- Provide input to DIA RIM AI Use Cases
Speaker(s)
Reflections from WHO
Samvel Azatyan, MD, PhD
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Senior Adviser
Reflections from Global Health Authorities on Convergence and Reliance
Nawaf Matar Almutairi, MPharm
Saudi Food and Drug Authority , Saudi Arabia
Regulatory Affairs Expert
Dmitriy Rozdestvensky, MD, PhD
Eurasian Economic Commission, Russian Federation
Head, Division for Coordination of Common Market for Drugs and Medical Devices F
Reflections from Global Health Authorities on Convergence and Reliance
Raphael Sanches Pereira
ANVISA, Brazil
General Manager of the Office for Medicines
Reflections from Industry on Convergence and Reliance
Isabelle Colmagne-Poulard, PharmD, MBA, MSc
Merck, Switzerland
Head, International Global Regulatory & Scientific Policy
Recent Successes in the use of WHO Reliance processes in MA and PAC: AZ perspective
Jinesh Patel, PhD, MS, RPh
Vertex Pharmaceuticals, United Kingdom
Associate Director, Regulatory Strategy